Anti-ATP citrate lyase antibody [EP704Y]
- RabMAb
- Recombinant
- KO Validated
- 20ul selling size
- What is this?
4
(2 Reviews)
|
(93 Publications)
Anti-ATP citrate lyase antibody [EP704Y] (ab40793) is a rabbit monoclonal antibody detecting ATP citrate lyase in Western Blot, Flow Cytometry (Intra), IP, IHC-P, ICC/IF. Suitable for Human, Mouse, Rat.
- KO validated for confirmed specificity
- Biophysical QC for unrivalled batch-batch consistency
- Over 60 publications
- Trusted since 2006
View Alternative Names
ATP-citrate synthase, ATP-citrate (pro-S-)-lyase, Citrate cleavage enzyme, ACL, ACLY
- Flow Cyt (Intra)
Lab
Flow Cytometry (Intracellular) - Anti-ATP citrate lyase antibody [EP704Y] (AB40793)
Flow cytometry overlay histogram showing left wild-type HAP1 positive cells and right negative ACLY knockout HAP1 stained with ab40793 (red line). The cells were fixed with 80% methanol (5 min) and then permeabilised with 0.1% PBS-Triton X-100 for 15 min. The cells were then incubated in 1x PBS containing 10% normal goat serum to block non-specific protein-protein interaction followed by the antibody (ab40793) (1x 106 in 100μl at 0.04 μg/ml (1/6225 dilution)) for 30min at 22°C.
The secondary antibody Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed was incubated at 1/4000 dilution for 30min at 22°C.
Isotype control antibody was Recombinant Rabbit IgG, monoclonal [EPR25A] - Isotype Control (black line) used at the same concentration and conditions as the primary antibody. Unlabelled sample (blue line) was also used as a control.
Acquisition of >5000 events were collected using a 50 mW Blue laser (488nm) and 530/30 bandpass filter.
This antibody gave a positive signal in wild-type HAP1 fixed with 4% formaldehyde (10 min) and then permeabilised with 0.1% PBS-Triton X-100 for 15 min under the same conditions.
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-ATP citrate lyase antibody [EP704Y] (AB40793)
Intracellular Flow Cytometry analysis of HeLa (Human cervix adenocarcinoma epithelial cell) cells labeling ATP citrate lyase with purified ab40793 at 1/30 dilution (red). Cells were fixed with 4% Paraformaldehyde. A Goat anti rabbit IgG (Alexa Fluor® 488) secondary antibody was used at 1/2000 dilution. Isotype control - Rabbit monoclonal IgG (Black). Unlabeled control - Cell without incubation with primary antibody and secondary antibody (Blue).
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ATP citrate lyase antibody [EP704Y] (AB40793)
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human clear cell carcinoma of kidney tissue sections labeling ATP citrate lyase with Purified ab40793 at 1 : 100 dilution. Heat mediated antigen retrieval was performed using ab93684 (Tris/EDTA buffer, pH 9.0). Tissue was counterstained with Hematoxylin. ImmunoHistoProbe one step HRP Polymer (ready to use) secondary antibody was used at 1 : 0 dilution. PBS instead of the primary antibody was used as the negative control.
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-ATP citrate lyase antibody [EP704Y] (AB40793)
Immunocytochemistry/Immunofluorescence analysis of HeLa cells labelling ATP citrate lyase with purified ab40793 at 1/50. Cells were fixed with 100% methanol. ab150077, an Alexa Fluor® 488-conjugated goat anti-rabbit IgG (1/1000) was used as the secondary antibody.
Control : PBS only.
Nuclear counter stain : DAPI.
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-ATP citrate lyase antibody [EP704Y] (AB40793)
Overlay histogram showing HeLa cells stained withunpurified ab40793 (red line). The cells were fixed with 80% methanol (5 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab40793, 1/100 dilution) for 30 min at 22°C. The secondary antibody used was DyLight® 488 goat anti-rabbit IgG (H+L) (ab96899) at 1/500 dilution for 30 min at 22°C. Isotype control antibody (black line) was rabbit IgG (monoclonal) (1μg/1x106 cells) used under the same conditions. Acquisition of >5,000 events was performed.
- IP
Unknown
Immunoprecipitation - Anti-ATP citrate lyase antibody [EP704Y] (AB40793)
ab40793 (purified) at 1 : 20 dilution (1.5μg) immunoprecipitating ATP citrate lyase in HeLa whole cell lysate.
Lane 1 (input) : HeLa (Human cervix adenocarcinoma epithelial cell) whole cell lysate,10μg
Lane 2 (+) : ab40793 & HeLa whole cell lysate
Lane 3 (-) : Rabbit monoclonal IgG (ab172730) instead of ab40793 in HeLa whole cell lysate.
For western blotting, VeriBlot for IP Detection Reagent (HRP) (ab131366) was used for detection at 1 : 1000 dilution.
Blocking and diluting buffer : 5% NFDM/TBST.
All lanes:
Immunoprecipitation - Anti-ATP citrate lyase antibody [EP704Y] (ab40793)
Predicted band size: 120 kDa
false
- IP
Unknown
Immunoprecipitation - Anti-ATP citrate lyase antibody [EP704Y] (AB40793)
ab40793 at 1/40 immunoprecipitating ATP citrate lyase in HeLa (human cervix adenocarcinoma) whole cell lysate.
Lane 1 (input) : HeLa (human cervix adenocarcinoma) whole cell lysate 10μg
Lane 2 (+) : ab40793 + HeLa (human cervix adenocarcinoma) whole cell lysate
Lane 3 (-) : Rabbit monoclonal IgG (ab172730) instead of ab40793 in HeLa (human cervix adenocarcinoma) whole cell lysate
For western blotting, ab40793 at 1/1000 dilution and ab131366 VeriBlot for IP (HRP) was used as the secondary antibody at 1/10000.
Blocking buffer and concentration : 5% NFDM/TBST.
Diluting buffer and concentration : 5% NFDM /TBST.
All lanes:
Immunoprecipitation - Anti-ATP citrate lyase antibody [EP704Y] (ab40793)
Predicted band size: 120 kDa
Observed band size: 122 kDa
false
Exposure time: 10s
- WB
Unknown
Western blot - Anti-ATP citrate lyase antibody [EP704Y] (AB40793)
All lanes:
Western blot - Anti-ATP citrate lyase antibody [EP704Y] (ab40793) at 1/5000 dilution
All lanes:
HeLa cell lysate
Predicted band size: 120 kDa
Observed band size: 122 kDa
false
- WB
Unknown
Western blot - Anti-ATP citrate lyase antibody [EP704Y] (AB40793)
Lane 1 : Wild-type HAP1 whole cell lysate (20 μg)
Lane 2 : ATP citrate lyase knockout HAP1 whole cell lysate (20 μg)
Lane 3 : HeLa whole cell lysate (20 μg)
Lanes 1 - 3 : Merged signal (red and green). Green - ab40793 observed at 125 kDa. Red - loading control, ab9484, observed at 37 kDa.
Unpurified ab40793 was shown to specifically react with ATP citrate lyase in wild-type HAP1 cells as signal was lost in ATP citrate lyase knockout cells. Wild-type and ATP citrate lyase knockout samples were subjected to SDS-PAGE. ab40793 and ab9484 (Mouse anti-GAPDH loading control) were incubated overnight at 4°C at 1/1000 dilution and 1/20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed ab216773 and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed ab216776 secondary antibodies at 1/20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-ATP citrate lyase antibody [EP704Y] (ab40793)
Predicted band size: 120 kDa
false
- WB
Lab
Western blot - Anti-ATP citrate lyase antibody [EP704Y] (AB40793)
Blocking and diluting buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-ATP citrate lyase antibody [EP704Y] (ab40793) at 1/50000 dilution
Lane 1:
HeLa (Human cervix adenocarcinoma epithelial cell) whole cell lysates at 20 µg
Lane 2:
NIH/3T3 (Mouse embryonic fibroblast) whole cell lysates at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 120 kDa
false
- WB
Lab
Western blot - Anti-ATP citrate lyase antibody [EP704Y] (AB40793)
Blocking and diluting buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-ATP citrate lyase antibody [EP704Y] (ab40793) at 1/10000 dilution
Lane 1:
Rat lung lysates at 15 µg
Lane 2:
C6 (Rat glial tumor glial cell) whole cell lysate at 15 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 120 kDa
false
Related conjugates and formulations (4)
-
Anti-ATP citrate lyase antibody [EP704Y] - BSA and Azide free
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-ATP citrate lyase antibody [EP704Y]
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-ATP citrate lyase antibody [EP704Y]
-
578 PE
PE Anti-ATP citrate lyase antibody [EP704Y]
Reactivity data
Product details
What is this antibody validated in?
Anti-ATP citrate lyase antibody [EP704Y] (ab40793) is a rabbit recombinant monoclonal antibody and is validated for use in Western Blot (WB), Flow Cytometry (Intra), Flow Cytometry (Flow Cyt), Immunoprecipitation (IP), Immunohistochemistry (IHC-P), Immunocytochemistry/immunofluorescence (ICC/IF) in Human, Mouse, Rat samples.
What is the molecular weight of ATP citrate lyase?
Anti-ATP citrate lyase [EP704Y] (ab40793) specifically detects a band for ATP citrate lyase (UniProt: P53396) at a molecular weight of 122kDa.
Trusted by the scientific community
Anti-ATP citrate lyase [EP704Y] (ab40793) was first used in a scientific publication in 2006 and has been cited over 60 times in peer-reviewed journals.
Trial sizes available!
Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 10µl. Discover our selection of trial-size antibodies.
Specificity confirmed
The specificity of Anti-ATP citrate lyase antibody [EP704Y] (ab40793) has been confirmed by Western blot testing in ATP citrate lyase Knockout HAP1 cells.
Other related products
We have a range of other formats of antibody clone [EP704Y] also available for your convenience: ab40793, Alexa Fluor® 488 - ab205429, Alexa Fluor® 647 - ab205430, PE - ab209750, Carrier free - ab227996
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
ATP citrate lyase plays an important role in lipid metabolism and energy production. It drives the conversion of citrate-derived acetyl-CoA a central metabolite in lipogenesis providing substrates for fatty acid and cholesterol synthesis. ACLY functions as a homotetramer complex to facilitate its enzymatic activity. This mechanism supports energy homeostasis linking carbohydrate metabolism with lipid biosynthesis.
Pathways
The enzyme ATP citrate lyase is instrumental in the citric acid cycle and fatty acid synthesis pathways. It is a central player in the cholesterol biosynthesis pathway which tightly connects to acetyl-CoA and citrate shuttle processes. In these pathways it interacts functionally with other enzymes such as acetyl-CoA carboxylase which further processes acetyl-CoA into malonyl-CoA serving as a precursor for fatty acid elongation.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (93)
Recent publications for all applications. Explore the full list and refine your search
Nature communications 16:8190 PubMed40897722
2025
Applications
Unspecified application
Species
Unspecified reactive species
Communications biology 8:471 PubMed40119138
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cell reports 44:115284 PubMed39932848
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cancer cell international 25:25 PubMed39871246
2025
Applications
Unspecified application
Species
Unspecified reactive species
International journal of biological sciences 21:614-631 PubMed39781455
2025
Applications
Unspecified application
Species
Unspecified reactive species
Science advances 10:eado5887 PubMed39454000
2024
Applications
Unspecified application
Species
Unspecified reactive species
Archives of toxicology 98:3859-3874 PubMed39192017
2024
Applications
Unspecified application
Species
Unspecified reactive species
Translational oncology 47:102056 PubMed38970915
2024
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of biological chemistry 300:107418 PubMed38815867
2024
Applications
Unspecified application
Species
Unspecified reactive species
Clinical and translational medicine 14:e1679 PubMed38706045
2024
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com